|
IRF2BP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.620200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.621400E-01 |
| Normal-vs-Stage2 |
9.742200E-01 |
| Normal-vs-Stage3 |
8.818400E-01 |
| Normal-vs-Stage4 |
6.442800E-01 |
| Stage1-vs-Stage2 |
9.566000E-01 |
| Stage1-vs-Stage3 |
8.409000E-01 |
| Stage1-vs-Stage4 |
6.398400E-01 |
| Stage2-vs-Stage3 |
9.240400E-01 |
| Stage2-vs-Stage4 |
6.040600E-01 |
| Stage3-vs-Stage4 |
5.345600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.147800E-01 |
| Normal-vs-AfricanAmerican |
8.069600E-01 |
| Normal-vs-Asian |
2.758000E-02 |
| Caucasian-vs-AfricanAmerican |
5.266000E-01 |
| Caucasian-vs-Asian |
7.985500E-02 |
| AfricanAmerican-vs-Asian |
6.893600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.844000E-01 |
| Normal-vs-Female |
2.178400E-01 |
| Male-vs-Female |
2.682600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.747200E-01 |
| Normal-vs-Extreme_Weight |
8.532200E-01 |
| Normal-vs-Obese |
3.044400E-01 |
| Normal-vs-Extreme_Obese |
5.854200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.138800E-01 |
| Normal_Weight-vs-Obese |
6.208600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.317800E-01 |
| Extreme_Weight-vs-Obese |
4.229400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.629200E-01 |
| Obese-vs-Extreme_Obese |
3.607800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.070000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.070200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.829400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.550400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.198400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.881400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.652200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.609500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.076800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.511800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.898100E-02 |
| Normal-VS-Type2 PRCC |
1.924420E-01 |
| Normal-VS-KIRP CIMP |
7.663600E-01 |
| Normal-VS-Unclassified PRCC |
7.159200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.581200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.228800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.306600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.794400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.598160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.505400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.561830E-01 |
| Normal-vs-N1 |
1.825980E-01 |
| Normal-vs-N2 |
1.092760E-01 |
| N0-vs-N1 |
3.081800E-02 |
| N0-vs-N2 |
4.629700E-02 |
| N1-vs-N2 |
6.946200E-01 |
|
|
